Shield Therapeutics plc (AIM:STX)
London
· Delayed Price · Currency is GBP · Price in GBX 2.400
-0.150 (-5.88%)
May 9, 2025, 4:35 PM GMT+1
Shield Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 6.52 | 13.95 | 3.4 | 16.41 | 4.01 | Upgrade
|
| Cash & Short-Term Investments | 6.52 | 13.95 | 3.4 | 16.41 | 4.01 | Upgrade
|
| Cash Growth | -53.23% | 309.99% | -79.27% | 308.75% | -26.81% | Upgrade
|
| Accounts Receivable | 12.28 | 9.99 | 3.39 | 1.1 | 0.3 | Upgrade
|
| Other Receivables | 10.54 | 1.23 | 1.13 | 1.3 | 0.6 | Upgrade
|
| Receivables | 22.81 | 11.21 | 4.52 | 2.4 | 0.9 | Upgrade
|
| Inventory | 5.66 | 3.2 | 1.76 | 2.21 | 1.88 | Upgrade
|
| Prepaid Expenses | 2.44 | 2.9 | 2.5 | 2.35 | 0.35 | Upgrade
|
| Restricted Cash | 0.5 | - | - | - | - | Upgrade
|
| Total Current Assets | 37.94 | 31.26 | 12.17 | 23.37 | 7.14 | Upgrade
|
| Property, Plant & Equipment | 0.37 | 0.67 | 0.24 | 0.41 | 0.04 | Upgrade
|
| Other Intangible Assets | 1.05 | 1.18 | 1.23 | 23.46 | 25.71 | Upgrade
|
| Long-Term Deferred Charges | 17.12 | 15.68 | 12.98 | 12.9 | 11.51 | Upgrade
|
| Other Long-Term Assets | 1 | - | - | - | - | Upgrade
|
| Total Assets | 57.48 | 48.8 | 26.62 | 60.14 | 44.41 | Upgrade
|
| Accounts Payable | 6.52 | 4.05 | 1.74 | 1.78 | 0.54 | Upgrade
|
| Accrued Expenses | 16.67 | 8.67 | 9.71 | 2.9 | 1.47 | Upgrade
|
| Current Portion of Leases | 0.2 | 0.21 | 0.11 | 0.21 | 0.04 | Upgrade
|
| Current Income Taxes Payable | 0.05 | 0.1 | 0.27 | 0.07 | 0.92 | Upgrade
|
| Other Current Liabilities | 9.19 | 0.7 | 1.01 | 0.08 | 0.11 | Upgrade
|
| Total Current Liabilities | 32.62 | 13.74 | 12.83 | 5.04 | 3.07 | Upgrade
|
| Long-Term Debt | 26.17 | 19.84 | 6.68 | - | - | Upgrade
|
| Long-Term Leases | - | 0.2 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.56 | - | - | Upgrade
|
| Total Liabilities | 58.8 | 33.77 | 20.07 | 5.04 | 3.07 | Upgrade
|
| Common Stock | 19.91 | 15.01 | 5.37 | 4.38 | 2.41 | Upgrade
|
| Additional Paid-In Capital | 203.19 | 198.76 | 169.48 | 155.15 | 120.63 | Upgrade
|
| Retained Earnings | -259.85 | -233.53 | -201.11 | -144.8 | -120.49 | Upgrade
|
| Comprehensive Income & Other | 35.43 | 34.79 | 32.8 | 40.36 | 38.79 | Upgrade
|
| Total Common Equity | -1.32 | 15.03 | 6.54 | 55.1 | 41.34 | Upgrade
|
| Shareholders' Equity | -1.32 | 15.03 | 6.54 | 55.1 | 41.34 | Upgrade
|
| Total Liabilities & Equity | 57.48 | 48.8 | 26.62 | 60.14 | 44.41 | Upgrade
|
| Total Debt | 26.37 | 20.25 | 6.79 | 0.21 | 0.04 | Upgrade
|
| Net Cash (Debt) | -19.85 | -6.3 | -3.39 | 16.2 | 3.98 | Upgrade
|
| Net Cash Growth | - | - | - | 307.37% | -27.16% | Upgrade
|
| Net Cash Per Share | -0.03 | -0.01 | -0.01 | 0.08 | 0.03 | Upgrade
|
| Filing Date Shares Outstanding | 1,042 | 782.06 | 259.39 | 215.89 | 117.62 | Upgrade
|
| Total Common Shares Outstanding | 1,042 | 782.06 | 259.39 | 215.89 | 117.62 | Upgrade
|
| Working Capital | 5.32 | 17.53 | -0.66 | 18.33 | 4.07 | Upgrade
|
| Book Value Per Share | -0.00 | 0.02 | 0.03 | 0.26 | 0.35 | Upgrade
|
| Tangible Book Value | -2.36 | 13.85 | 5.31 | 31.64 | 15.62 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | 0.02 | 0.02 | 0.15 | 0.13 | Upgrade
|
| Machinery | 0.51 | 0.48 | 0.24 | 0.27 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.